PolyCTLDesigner: A computational tool for constructing polyepitope T-cell antigens

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Antonets, Denis V ^a   Bazhan, Sergei I ^a  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

Cytotoxic T cell; Directed weighted graph; Polyepitope; Proteasome; T cell epitope; Transporters associated with antigen processing; Travelling salesman problem

Indexed keywords

ANTIGEN; EPITOPE;

ARTICLE; BIOLOGY; COMPUTER PROGRAM; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; METHODOLOGY;

ANTIGENS; COMPUTATIONAL BIOLOGY; EPITOPES, T-LYMPHOCYTE; HUMANS; SOFTWARE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84885025604     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-407     Document Type: Article

References (45)

1. Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995. Berzofsky JA, Berkower IJ, AIDS 1995 9 A 143 S157 8819581
2. Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes. Woodberry T, Gardner J, Mateo L, Eisen D, Medveczky J, Ramshaw IA, Thomson SA, Ffrench RA, Elliott SL, Firat H, Lemonnier FA, Suhrbier A, J Virol 1999 73 5320 5325 10364278 (Pubitemid 29274813)
3. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens. Bazhan SI, Belavin PA, Seregin SV, Danilyuk NK, Babkina IN, Karpenko LI, Nekrasova NA, Lebedev LR, Ignatyev GM, Agafonov AP, Poryvaeva VA, Aborneva IV, Ilyichev AA, Vaccine 2004 22 1672 1682 10.1016/j.vaccine.2003.09.048 15068850 (Pubitemid 38447215)
4. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct. Cardinaud S, Bouziat R, Rohrlich P-S, Tourdot S, Weiss L, Langlade-Demoyen P, Burgevin A, Fiorentino S, Van Endert P, Lemonnier FA, AIDS 2009 23 1945 1954 10.1097/QAD.0b013e32832fae88 19644347
5. Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo. Iglesias MC, Mollier K, Beignon A-S, Souque P, Adotevi O, Lemonnier F, Charneau P, Molec Ther 2007 15 1203 1210 (Pubitemid 46813625)
6. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes. Tine JA, Firat H, Payne A, Russo G, Davis SW, Tartaglia J, Lemonnier FA, Demoyen PL, Moingeon P, Vaccine 2005 23 1085 1091 10.1016/j.vaccine.2003.01.001 15620483 (Pubitemid 40037659)
7. Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses. Bazhan SI, Karpenko LI, Ilyicheva TN, Belavin PA, Seregin SV, Danilyuk NK, Antonets DV, Ilyichev AA, Molec Immunol 2010 47 1507 1515 10.1016/j.molimm.2010.01.020
8. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, Del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A, J Immunol 1999 162 3915 3925 10201910 (Pubitemid 29314770)
9. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Livingston BD, Newman M, Crimi C, McKinney D, Chesnut R, Sette A, Vaccine 2001 19 4652 4660 10.1016/S0264-410X(01)00233-X 11535313 (Pubitemid 32800747)
10. Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. Bonehill A, Heirman C, Tuyaerts S, Michiels A, Breckpot K, Brasseur F, Zhang Y, Van Der Bruggen P, Thielemans K, J Immunol 2004 172 6649 6657 15153480 (Pubitemid 38669100)
11. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. Bonini C, Lee SP, Riddell SR, Greenberg PD, J Immunol 2001 166 5250 5257 11290810 (Pubitemid 32280742)
12. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Su Z, Vieweg J, Weizer AZ, Dahm P, Yancey D, Turaga V, Higgins J, Boczkowski D, Gilboa E, Dannull J, Cancer Res 2002 62 5041 5048 12208759 (Pubitemid 34984432)
13. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. Kim TW, Hung C-F, Boyd D, Juang J, He L, Kim JW, Hardwick JM, Wu T-C, J Immunol 2003 171 2970 2976 12960321 (Pubitemid 37093519)
14. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, Nair S, Gilboa E, Clini Cancer Res 2005 11 5566 5571 10.1158/1078-0432.CCR-05-0699 (Pubitemid 41060834)
15. An HLA-A2 polyepitope vaccine for melanoma immunotherapy. Mateo L, Gardner J, Chen Q, Schmidt C, Down M, Elliott SL, Pye SJ, Firat H, Lemonnier FA, Cebon J, Suhrbier A, Journal of immunology 1999 163 4058 4063 (Pubitemid 29450937)
16. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses. Smith SG, Patel PM, Porte J, Selby PJ, Jackson AM, Clin Cancer Res 2001 7 4253 4261 11751527 (Pubitemid 34044652)
17. ProPred1: prediction of promiscuous MHC Class-I binding sites. Singh H, Raghava GPS, Bioinformatics 2003 19 1009 1014 10.1093/bioinformatics/btg108 12761064 (Pubitemid 36675822)
18. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M, Nuc Acids Res 2008 36 509 W512 10.1093/nar/gkn202
19. Machine learning competition in immunology-prediction of HLA class I binding peptides. Zhang GL, Ansari HR, Bradley P, Cawley GC, Hertz T, Hu X, Jojic N, Kim Y, Kohlbacher O, Lund O, Lundegaard C, Magaret CA, Nielsen M, Papadopoulos H, Raghava GPS, Tal V-S, Xue LC, Yanover C, Zhu S, Rock MT, Crowe JE, Panayiotou C, Polycarpou MM, Duch W, Brusic V, J Immunol Methods 2011 374 1 4 10.1016/j.jim.2011.09.010 21986107
20. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. Bhasin M, Raghava GPS, J Biosci 2007 32 31 42 10.1007/s12038-007-0004-5 17426378 (Pubitemid 46465755)
21. An algorithm for the prediction of proteasomal cleavages. Kuttler C, Nussbaum AK, Dick TP, Rammensee H, Hadeler K, J Mol Biol 2000 301 229
22. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. Toes RE, Nussbaum AK, Degermann S, Schirle M, Emmerich NP, Kraft M, Laplace C, Zwinderman A, Dick TP, Müller J, Schönfisch B, Schmid C, Fehling HJ, Stevanovic S, Rammensee HG, Schild H, J Exp Med 2001 194 1 12 10.1084/jem.194.1.1 11435468 (Pubitemid 32660433)
23. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Nussbaum AK, Kuttler C, Hadeler KP, Rammensee HG, Schild H, Immunogenetics 2001 53 87 94 10.1007/s002510100300 11345595 (Pubitemid 32289623)
24. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, Lund O, Nielsen M, Eur J Immunol 2005 35 2295 2303 10.1002/eji.200425811 15997466 (Pubitemid 41179750)
25. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Nielsen M, Lundegaard C, Lund O, Keşmir C, Immunogenetics 2005 57 33 41 10.1007/s00251-005-0781-7 15744535 (Pubitemid 40591245)
26. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. Peters B, Bulik S, Tampe R, Van Endert PM, Holzhütter H-G, J Immunol 2003 171 1741 1749 12902473 (Pubitemid 36966457)
27. Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation. Doytchinova I, Hemsley S, Flower DR, J Immunol 2004 173 6813 6819 15557175 (Pubitemid 39541067)
28. Characterization of the binding profile of peptide to transporter associated with antigen processing (TAP) using Gaussian process regression. Ren Y, Wu B, Pan Y, Lv F, Kong X, Luo X, Li Y, Yang Q, Computers Biol Med 2011 41 865 870 10.1016/j.compbiomed.2011.07.004
29. Emerging vaccine informatics. He Y, Rappuoli R, De Groot AS, Chen RT, J Biomed Biotechnol 2010 2010 218590 21772787
30. Estimating design space available for polyepitopes through consideration of major histocompatibility complex binding motifs. Lee Y, Ferrari G, Lee SC, Biomed Microdevices 2010 12 207 222 10.1007/s10544-009-9376-7 20033850
31. Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism. Altuvia Y, Margalit H, J Mol Biol 2000 295 879 890 10.1006/jmbi.1999.3392 10656797
32. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N, Nature 2002 419 480 483 10.1038/nature01074 12368856
33. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Neefjes J, Jongsma MLM, Paul P, Bakke O, Nat Rev Immunol 2011 11 823 836 22076556
34. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. Mo XY, Cascio P, Lemerise K, Goldberg AL, Rock K, J Immunol 1999 163 5851 5859 10570269
35. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Craiu A, Akopian T, Goldberg A, Rock KL, Proc Natl Acad Sci U S A 1997 94 10850 10855 10.1073/pnas.94.20.10850 9380723 (Pubitemid 27430824)
36. Single Locus Polymorphism of Classical HLA Genes. Meyer D, Singe RM, Mack SJ, Lancaster A, Nelson MP, Erlich H, Fernandez-Vina M, Thomson G, Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference, Volume I Seattle, WA: IHWG Press, Hansen JA, 2007 653 704
37. TEpredict: Software for T-Cell epitope prediction. Antonets DV, Maksyutov AZ, Mol Biol 2010 44 119 127 10.1134/S0026893310010152
38. Pyevolve: Genetic Algorithm framework written in pure python http://pyevolve.sourceforge.net
39. ProPred: prediction of HLA-DR binding sites. Singh H, Raghava GP, Bioinformatics 2001 17 1236 1237 10.1093/bioinformatics/17.12.1236 11751237 (Pubitemid 33735355)
40. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP, Sinigaglia F, Hammer J, Nature Biotechnol 1999 17 555 561 10.1038/9858 (Pubitemid 29262918)
41. How TCRs bind MHCs, peptides, and coreceptors. Rudolph MG, Stanfield RL, Wilson IA, Ann Rev Immunol 2006 24 419 466 10.1146/annurev.immunol.23.021704. 115658
42. Cutting edge: introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. Schneider SC, Ohmen J, Fosdick L, Gladstone B, Guo J, Ametani A, Sercarz EE, Deng H, J Immunol 2000 165 20 23 10861030 (Pubitemid 30429485)
43. Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells. Zhu H, Liu K, Cerny J, Imoto T, Moudgil KD, J Immunol 2005 175 2252 2260 16081793 (Pubitemid 41113832)
44. python-graph-a library for working with graphs in Python http://code.google.com/p/python-graph/
45. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Cock PJA, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, Friedberg I, Hamelryck T, Kauff F, Wilczynski B, De Hoon MJL, Bioinformatics 2009 25 1422 1423 10.1093/bioinformatics/btp163 19304878